Tom van Gils, Hans Törnblom, Floris van Overveld, Olafur S Palsson, Ami D Sperber, Shrikant I Bangdiwala, Inês A Trindade, Marc A Benninga, Gerd Bouma, Magnus Simrén
{"title":"Symptom Profiles Compatible With Disorders of Gut-Brain Interaction in Individuals With Coeliac Disease on a Long-Term Gluten-Free Diet.","authors":"Tom van Gils, Hans Törnblom, Floris van Overveld, Olafur S Palsson, Ami D Sperber, Shrikant I Bangdiwala, Inês A Trindade, Marc A Benninga, Gerd Bouma, Magnus Simrén","doi":"10.1002/ueg2.70311","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Persistent gastrointestinal (GI) symptoms are frequently reported in patients with coeliac disease (CD). Knowledge about the role of disorders of gut-brain interaction (DGBI) as the cause of these persistent symptoms remains limited.</p><p><strong>Objective: </strong>To assess the prevalence and factors associated with DGBI-compatible symptom profiles in individuals with CD on a long-term gluten-free diet (GFD).</p><p><strong>Methods: </strong>Adult members of the Dutch Coeliac Society completed an online survey, including the Rome IV diagnostic questionnaire and validated questionnaires assessing psychological distress, non-GI somatic symptom severity, and health-related quality of life (QOL). Only individuals with CD adhering to a GFD ≥ 1 year were included. A population-based Dutch cohort served as the reference group.</p><p><strong>Results: </strong>Among 1001 participants with CD (79.3% female; median age 50 years), 64.8% met the criteria for ≥ 1 DGBI-compatible symptom profile compared with 31.3% in the reference group (for confounders adjusted odds ratio (AOR) 3.2 (95% CI 2.6-3.8)). Irritable bowel syndrome showed the strongest association with CD (AOR 4.5 (95% CI 3.3-6.2)). Having DGBI-compatible symptom profiles was, like the reference group, associated with higher levels of psychological distress and non-GI somatic symptom severity and lower health-related QOL.</p><p><strong>Conclusions: </strong>Rome IV DGBI-compatible symptom profiles are highly prevalent in individuals with CD on a long-term GFD and are associated with impaired QOL. While ongoing gluten exposure and other comorbidities could not be excluded, these findings support the consideration of DGBI in the evaluation and treatment of persistent symptoms in patients with CD.</p>","PeriodicalId":23444,"journal":{"name":"United European Gastroenterology Journal","volume":"14 8","pages":"e70311"},"PeriodicalIF":6.4000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13675726/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"United European Gastroenterology Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ueg2.70311","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Persistent gastrointestinal (GI) symptoms are frequently reported in patients with coeliac disease (CD). Knowledge about the role of disorders of gut-brain interaction (DGBI) as the cause of these persistent symptoms remains limited.
Objective: To assess the prevalence and factors associated with DGBI-compatible symptom profiles in individuals with CD on a long-term gluten-free diet (GFD).
Methods: Adult members of the Dutch Coeliac Society completed an online survey, including the Rome IV diagnostic questionnaire and validated questionnaires assessing psychological distress, non-GI somatic symptom severity, and health-related quality of life (QOL). Only individuals with CD adhering to a GFD ≥ 1 year were included. A population-based Dutch cohort served as the reference group.
Results: Among 1001 participants with CD (79.3% female; median age 50 years), 64.8% met the criteria for ≥ 1 DGBI-compatible symptom profile compared with 31.3% in the reference group (for confounders adjusted odds ratio (AOR) 3.2 (95% CI 2.6-3.8)). Irritable bowel syndrome showed the strongest association with CD (AOR 4.5 (95% CI 3.3-6.2)). Having DGBI-compatible symptom profiles was, like the reference group, associated with higher levels of psychological distress and non-GI somatic symptom severity and lower health-related QOL.
Conclusions: Rome IV DGBI-compatible symptom profiles are highly prevalent in individuals with CD on a long-term GFD and are associated with impaired QOL. While ongoing gluten exposure and other comorbidities could not be excluded, these findings support the consideration of DGBI in the evaluation and treatment of persistent symptoms in patients with CD.
背景:乳糜泻(CD)患者经常报告持续的胃肠道(GI)症状。关于肠脑相互作用障碍(DGBI)作为这些持续症状的原因的作用的知识仍然有限。目的:评估长期无谷蛋白饮食(GFD)的乳糜泻患者dgbi相容症状的患病率和相关因素。方法:荷兰乳糜泻协会的成年成员完成了一项在线调查,包括Rome IV诊断问卷和评估心理困扰、非gi躯体症状严重程度和健康相关生活质量(QOL)的有效问卷。仅包括坚持GFD≥1年的CD患者。以人群为基础的荷兰队列作为参照组。结果:在1001名CD患者中(79.3%为女性,中位年龄50岁),64.8%符合≥1个dgbi相容症状特征的标准,而参照组为31.3%(校正混杂因素的优势比(AOR)为3.2 (95% CI 2.6-3.8))。肠易激综合征与CD的相关性最强(AOR为4.5 (95% CI 3.3-6.2))。与对照组一样,具有dgbi相容的症状特征与较高水平的心理困扰和非胃肠道躯体症状严重程度以及较低的健康相关生活质量相关。结论:罗马IV dgbi相容症状在长期GFD的CD患者中非常普遍,并与生活质量受损相关。虽然不能排除持续的麸质暴露和其他合并症,但这些发现支持在评估和治疗乳糜泻患者持续症状时考虑DGBI。
期刊介绍:
United European Gastroenterology Journal (UEG Journal) is the official Journal of the United European Gastroenterology (UEG), a professional non-profit organisation combining all the leading European societies concerned with digestive disease. UEG’s member societies represent over 22,000 specialists working across medicine, surgery, paediatrics, GI oncology and endoscopy, which makes UEG a unique platform for collaboration and the exchange of knowledge.